The present invention discloses a novel use of a pharmaceutical composition in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction, in particular to the use of ACl inhibitor NB001 and AC1 &8 mixed inhibitors NB010 and NB011 in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction.
本发明公开了一种药物组合物在制备治疗阿片类药物引起的耐受性和成瘾的药物中的新用途,特别是ACl
抑制剂NB001和AC1 & 8混合
抑制剂NB010和NB011在制备治疗阿片类药物引起的耐受性和成瘾的药物中的用途。